The upcoming International Plasma Protein Congress (IPPC) in Milan brings together two powerful perspectives: the economic impact of plasma-derived medicines and the science of high performance under pressure. This year’s keynote speakers, Nikolaj Siersbæk and David Osgathorp, offer insights that are both highly specialized and broadly applicable across the plasma sector.
From health care policy to elite performance, their sessions will equip attendees with practical tools to navigate complexity, improve outcomes, and build sustainable systems.
The Future of Plasma-Derived Medicines in Europe
Nikolaj Siersbæk, Managing Economist at Copenhagen Economics, will present new findings from a follow-up report to the influential 2021 study on plasma-derived medicines in Europe.
Why Plasma-Derived Medicines Matter
Plasma-derived medicines are essential for treating patients with rare and chronic conditions, including immune deficiencies and bleeding disorders. As clinical need continues to rise, ensuring equitable access and sustainable supply is becoming a top priority for health care systems across Europe.
What This Keynote Will Cover
Drawing on rigorous research and economic modeling, Siersbæk will explore:
- The economic contribution of plasma-derived medicines in Europe
- The value to health care systems and patients
- The policy and procurement frameworks needed for long-term sustainability
Key Takeaways for Attendees
Participants can expect actionable insights, including:
- Strategies to secure a sustainable plasma supply
- Approaches to optimize procurement and policy frameworks
- A deeper understanding of how economic evidence supports patient access
This session will be especially valuable for policymakers, payers, and industry leaders working to balance cost, access, and innovation in plasma care.
High Performance Lessons from Formula One
Switching gears, David Osgathorp of Oracle Red Bull Racing will bring lessons from the fast-paced world of Formula One into the health care space. With more than 20 years of experience supporting elite athletes, executives, and high-performing teams, Osgathorp offers a unique perspective on how to sustain excellence under pressure.
Performance in High-Stakes Environments
In both motorsport and health care, decisions must be made quickly and accurately, often under intense pressure. Osgathorp’s keynote will focus on:
- Improving decision-making under pressure
- Maintaining focus and clarity in complex environments
- Building routines that support consistent high performance
Building Resilient Individuals and Teams
Beyond individual performance, this session emphasizes the importance of team alignment and organizational resilience.
Attendees will learn how to:
- Develop resilient habits for long-term success
- Align energy, mindset, and execution
- Create systems that enable sustained performance, not burnout
Where Plasma Meets Performance
While these two keynotes approach the plasma sector from very different angles, they share a common goal: improving outcomes in complex, high-stakes environments.
- Siersbæk provides the economic and policy foundation needed to ensure access to plasma-derived medicines
- Osgathorp delivers the human performance strategies required to execute effectively within those systems
Together, they offer a holistic view of what it takes to move the plasma sector forward from policy and procurement to people and performance.
Why You Should Attend IPPC
IPPC is more than a conference, it’s a platform for advancing the future of plasma-derived medicines through collaboration, innovation, and shared expertise.
By attending these keynote sessions, you will gain:
- Evidence-based insights into plasma-derived medicines and European health care systems
- Practical tools for leading and performing under pressure
- A broader perspective on how to build resilient, sustainable health care ecosystems
Ready to gain actionable insights and connect with leaders shaping the future of plasma-derived medicines? Register now to secure your place at IPPC and be part of the conversation driving innovation, policy, and performance in the plasma sector.
Don’t miss the opportunity to learn from global experts, exchange ideas, and help shape a more sustainable future for patients worldwide.